• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Allele expression levels may hold the key to graft-versus-host disease levels

byShaidah Deghan, MSc. MD
August 13, 2015
in Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. After transplant, graft-versus-host disease (GVHD) was more likely when the recipient had a high-expression allele and the donor had a low-expression allele.

2. Further studies investigating the effects of mismatching multiple low-expression HLA alleles compared to multiple high-expression alleles are needed.

Evidence Rating Level: 2 (Good)           

Study Rundown: GVHD is a major obstacle in the successful hematopietic-cell transplantation of unrelated donors for the cure of blood disorders. GVHD can occur when HLA-matched donor cells recognize the recipient’s HLA cells. The rs2281389 variant has been associated with acute GVHD though it is not a direct mediator of it. This variant is strongly associated with rs9277534 allele in the HLA-DPB1 regulatory region, which has been shown to be associated with life-threatening GVHD. This close relationship may mark the connection for the risk of GVHD.

This study evaluated the risk associated with GVHD and rs9277534G-linked HLA-DPB1 mismatches compared to rs9277534A-linked mismatches. A total of 3505 persons were genotyped for rs9277534. Clinical outcomes were evaluated in 2029 transplant recipients for leukemia, chronic myeloid leukemia or myelodysplastic syndrome from unrelated donors. The study showed that rs9277534A-linked HLA-DPB1 alleles were expressed at a lower level compared to the rs9277534G-linked alleles. Furthermore, compared with recipients who had rs9277534A-linked mismatches, transplant recipients with rs9277534G-linked HLA-DPB1 mismatches had higher risks of grade 2,3, or 4 acute GVHD and of grade 3 or 4 disease but showed a lower risk of relapse. The overall mortality between the two groups remained the same. Results show that rs9277534G recipients from rs9277534A-linked donors had higher risks of grade 2,3, or 4 acute GVHD and of grade 3 or 4 disease than rs9277534A recipients. The study demonstrates that HLA-DPB1 mismatch on its own is not enough to cause GVHD and that genotyping for alleles such as rs9277534 may reduce the number of transplantation involving high-risk mismatches.

Click to read the study, published today in NEJM

RELATED REPORTS

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

Relevant Reading: Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study

In-Depth [retrospective cohort]: The study population included genetic results from 2029 individuals. The primary end point for this study was acute GVHD (assessed as grade 2,3, or 4 and as grade 3 or 4). Secondary end point were chronic GVHD, relapse, death not preceded by relapse, and death from any cause. In this study sample, the rs9277534A-linked HLA-DPB1 alleles were expressed at lower levels than rs9277534G-linked alleles (mean difference in expression, -10.33; 95% [CI], -14.95 to -5.70; p<0.001). Recipients of the rs9277534G-linked HLA-DPB1 mismatches were at higher risk of grade 2,3, or 4 acute GVHD (HR = 1.32; 95% [CI], 1.13-1.55; p<0.001) and of grade 3 or 4 disease (HR = 1.34; 95% [CI], 1.08-1.68; p=0.009) as compared to those of rs9277534A-linked mismatches. Recipients with rs9277534G-linked mismatches had a lower risk of relapse compared to rs9277534A-linked recipients (HR = 0.80; 95%CI, 0.64 – 0.99; p=0.04). Recipients with rs9277534G from donors with rs9277534A had higher risks of grade 2,3,or4 acute GVHD (HR = 1.54; 95% [CI], 1.25-1.89; p<0.001) and grade 3 or 4 disease (HR = 1.50; 95% [CI], 1.12-2.01; p=0.007) than recipients with rs9277534A and the same donor type. The overall mortality between the two groups was the same.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: graft versus host
Previous Post

Dietary doses of resveratrol may inhibit development of colorectal cancer [PreClinical]

Next Post

Use of elotuzumab with conventional therapy linked to improved survival in multiple myeloma patients

RelatedReports

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children
StudyGraphics

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children

February 17, 2022
#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft
StudyGraphics

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

October 28, 2021
#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients
StudyGraphics

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

June 25, 2021
Quick Take: Factors associated with successful discontinuation of immune suppression after allogenic hematopoietic cell transplantation
Chronic Disease

Quick Take: Factors associated with successful discontinuation of immune suppression after allogenic hematopoietic cell transplantation

October 7, 2019
Next Post
Phase III trial shows survival benefit for early multiple myeloma

Use of elotuzumab with conventional therapy linked to improved survival in multiple myeloma patients

Diet and physical activity promotion associated with decreased risk of type 2 diabetes

Troponin T levels may be a predictor of mortality in diabetes and heart disease patients: BAR 2D Trial

Distinct NICU newborn naming linked to reduced error

No change in perinatal outcomes with fetal electrocardiogram

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
  • #VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options